Latent variable modeling and its implications for institutional review board review: variables that delay the reviewing process
BMC Medical Ethics 16 (1):1-7 (2015)
AbstractBackgroundTo investigate the factors related to approval after review by an Institutional Review Board, the structure equation model was used to analyze the latent variables ‘investigators’, ‘vulnerability’ and ‘review process’ for 221 proposals submitted to our IRB.MethodsThe vulnerability factor included vulnerable cases, and studies that involved drug tests and genetic analyses. The principal investigator factor included the license level of the PI and whether they belonged to our institution. The review factor included administration time, total review time, and revision frequency. The revision frequency and total review time influenced the efficiency of review.ResultsThe latent variable of reviewing was the most important factor mediating the PIs and vulnerability to IRB review approval. The local PIs moderated with genetic study and revision frequency had an impact on the review process and mediated non-approval.ConclusionsBetter guidance of the investigators and reviewers might improve the efficiency with which IRBs function
Similar books and articles
The Stipulations of One Institutional Review Board: A Five Year Review.R. A. Sansone - 2004 - Journal of Medical Ethics 30 (3):308-310.
Symptoms as Latent Variables.Dennis J. McFarland & Loretta S. Malta - 2010 - Behavioral and Brain Sciences 33 (2-3):165 - 166.
Factors That Influence Institutional Review Board Members' Commitment to Their Role Responsibilities.Danielle Whicher, Peter Currie & Holly Taylor - 2009 - IRB: Ethics & Human Research 31 (5):15-19.
Some Opinions on the Review Process of Research Papers Destined for Publication.Ehsan Roohi & Omid Mahian - 2015 - Science and Engineering Ethics 21 (3):809-812.
Review of the Ethics and Etiquettes of Time Management of Manuscript Peer Review. [REVIEW]Malhar N. Kumar - 2014 - Journal of Academic Ethics 12 (4):333-346.
A Study To Evaluate The Effect Of Investigator Attendance On The Efficiency Of Irb Review.Holly Taylor, Peter Currie & Nancy Kass - 2008 - IRB: Ethics & Human Research 30 (1):1-5.
Rethinking Local Institutional Review Board (IRB) Review at State Health Departments: Implications for a Consolidated, Independent Public Health IRB.David Perlman - 2012 - Journal of Law, Medicine and Ethics 40 (4):997-1007.
Looking From the Outside/In: Re-Thinking Research Ethics Review. [REVIEW]Dominique Rivière - 2011 - Journal of Academic Ethics 9 (3):193-204.
Latent Variables and the Network Perspective.Catherine Belzung, Etienne Billette De Villemeur, Mael Lemoine & Vincent Camus - 2010 - Behavioral and Brain Sciences 33 (2-3):150-1.
Research Monitoring by US Medical Institutions to Protect Human Subjects: Compliance or Quality Improvement?Jean Philippe de Jong, Myra C. B. van Zwieten & Dick L. Willems - 2013 - Journal of Medical Ethics 39 (4):236-241.
Is There a Contradiction Between the Network and Latent Variable Perspectives?Stephen M. Humphry & Joshua A. McGrane - 2010 - Behavioral and Brain Sciences 33 (2-3):160 - 161.
Stop Drinking the Kool-Aid: The Academic Journal Review Process in the Social Sciences Is Broken, Let’s Fix It.Jeffrey Overall - 2015 - Journal of Academic Ethics 13 (3):277-289.
A Commentary on Dr. Kennedy's Perception of the Impact of Institutional Review Boards on Cancer Research.Herman Wigodsky - 1984 - Journal of Bioethics 5 (1):33-40.
Ethics Review of Social, Behavioral, and Economic Research: Where Should We Go From Here'.Raymond De Vries, Debra A. DeBruin & Andrew Goodgame - 2004 - Ethics and Behavior 14 (4):351 – 368.
Added to PP
Historical graph of downloads
Citations of this work
No citations found.
References found in this work
Does Clinical Equipoise Apply to Cluster Randomized Trials in Health Research?Ariella Binik, Charles Weijer, Andrew McRae, Jeremy Grimshaw, Monica Taljaard, Robert Boruch, Jamie Brehaut, Allan Donner, Martin Eccles, Antonio Gallo, Raphael Saginur & Merrick Zwarenstein - 2011 - Trials 12.
Ethical Issues Posed by Cluster Randomized Trials in Health Research.Charles Weijer, Jeremy M. Grimshaw, Monica Taljaard, Ariella Binik, Robert Boruch, Jamie C. Brehaut, Allan Donner, Martin P. Eccles, Antonio Gallo, Andrew D. McRae & Ray Saginur - 2011 - Trials 1 (12):100.
Individual Genetic and Genomic Research Results and the Tradition of Informed Consent: Exploring US Review Board Guidance.Christian Simon, Laura A. Shinkunas, Debra Brandt & Janet K. Williams - 2012 - Journal of Medical Ethics 38 (7):417-422.